Abiopharma

🔍 Holme Timothy (Executive)

Company: QuantumScape Corp (QS)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 12,723 shares of Class A Common Stock (Direct)
  Date: 2026-08-21 | Code: C | equity_swap_involved: false | shares_owned_after: 12,723.00 | transaction_form_type: 4
• Sold 12,723 shares of Class A Common Stock at $6.014 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 12,723 shares of Class B Common Stock (Derivative)
  Date: 2026-08-21 | Code: C | equity_swap_involved: false | shares_owned_after: 1,212,357.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3

Footnotes:

• F1: The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2025.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.955 to $6.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the Reporting Person's election and has no expiration date.